Evidence map›Paper›PMID 27583352›Full record

ArticleInternational braz j urol : official journal of the Brazilian Society of Urology

The hOGG1 Ser326Cys gene polymorphism and susceptibility for bladder cancer: a meta-analysis.

Cao Wenjuan, Lu Jianzhong, Li Chong, Gao Yanjun, Lu Keqing, Wang Hanzhang, Wang Zhiping

Open access · diamondAbstract read
In one paragraph

Article in International braz j urol : official journal of the Brazilian Society of Urology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Cao WenjuanInstitute of Urology, The Second Hospital of Lanzhou University, Key Laboratory of Urological Diseases in Gansu Province, Gansu Nephro - Urological Clinical Center, Lanzhou, China.
Lu JianzhongInstitute of Urology, The Second Hospital of Lanzhou University, Key Laboratory of Urological Diseases in Gansu Province, Gansu Nephro - Urological Clinical Center, Lanzhou, China.
Li ChongInstitute of Urology, The Second Hospital of Lanzhou University, Key Laboratory of Urological Diseases in Gansu Province, Gansu Nephro - Urological Clinical Center, Lanzhou, China.
Gao YanjunInstitute of Urology, The Second Hospital of Lanzhou University, Key Laboratory of Urological Diseases in Gansu Province, Gansu Nephro - Urological Clinical Center, Lanzhou, China.
Lu KeqingInstitute of Urology, The Second Hospital of Lanzhou University, Key Laboratory of Urological Diseases in Gansu Province, Gansu Nephro - Urological Clinical Center, Lanzhou, China.
Wang HanzhangDepartment of Urology, University of Texas Health Science Center San Antonio, San Antonio, Texas, USA.
Wang ZhipingInstitute of Urology, The Second Hospital of Lanzhou University, Key Laboratory of Urological Diseases in Gansu Province, Gansu Nephro - Urological Clinical Center, Lanzhou, China.
Lanzhou University · CNLanzhou University Second Hospital · CNThe University of Texas Health Science Center at San Antonio · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo assess the susceptibility of the hOGG1 genetic polymorphism for bladder cancer and evaluate the impact of smoking exposure. MATERIALS AND

methodsArticles included in PubMed, Medline and Springer databases were retrieved using the following key words: "human 8-oxoguanine DNA glycosyl¬ase", "OGG", "OGG1", "hOGG1", "genetic variation", "polymorphism" , "bladder cancer", and "bladder carcinoma" to Meta-analysis was performed to detect whether there were differences between the bladder cancer group and the control group about the distribution of genotypes of the hOGG1 gene.

resultsThe results showed that there are no significant associations between the hOGG1 326Cys polymorphism and bladder cancer: GG vs CC (OR: 1.09, 95% CI: 0.85- 1.40, p=0.480); GC vs CC (OR: 1.05, 95% CI: 0.85-1.28, p=0.662); GG+GC vs CC (OR: 1.04, 95% CI: 0.89-1.21, p=0.619); GG vs GC+CC (OR: 1.02, 95% CI: 0.78-1.33, p=0.888); G vs C (OR: 1.01, 95% CI: 0.91-1.13, p=0.818). In the smoker population, no significant associations between the hOGG1 326Cys polymorphism and bladder cancer were observed for all the models. However, individuals carrying the hOGG1 Cys326Cys genotype have increased risk for bladder cancer compared to those carrying the hOGG1 Ser326Ser genotype in the non-smoker Asian population.

conclusionThe hOGG1 326Cys polymorphisms aren't a risk factor for bladder cancer, especially in the smoker population. But GG genotype is a risk factor for bladder cancer to the non-smoker Asian population compared with CC genotype.

Indexed as

Meta-Analysis as Topicoxoguanine glycosylase 1, human [Supplementary Concept]Polymorphism, Genetic

Identifiers

PMID27583352
PMCPMC5066884
OpenAlexW2528968530

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.